75 related articles for article (PubMed ID: 36207582)
1. Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects.
Arif S; Pujol-Autonell I; Kamra Y; Williams E; Yusuf N; Domingo-Vila C; Shahrabi Y; Pollock E; Khatri L; Peakman M; Tree T; Lorenc A
Front Immunol; 2021; 12():675746. PubMed ID: 34262563
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets.
Callebaut A; Guyer P; Derua R; Buitinga M; Manganaro A; Yi X; Sodré FMC; Vig S; Suleiman M; Marchetti P; Eizirik DL; Kent SC; Mathieu C; James EA; Overbergh L
Diabetes; 2024 May; 73(5):728-742. PubMed ID: 38387030
[TBL] [Abstract][Full Text] [Related]
3. The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.
Groegler J; Callebaut A; James EA; Delong T
Diabetologia; 2024 May; ():. PubMed ID: 38811417
[TBL] [Abstract][Full Text] [Related]
4. Generation of Autoantibodies in Metal-catalyzed Oxidatively Damaged DNA in Various Cancer Subjects.
Ahmad S; Alshammari QT; Rafi Z; Rehman S; Khan MY; Faisal M; Alatar AA
Curr Med Chem; 2024; 31(5):640-648. PubMed ID: 37138484
[TBL] [Abstract][Full Text] [Related]
5. The immunology of type 1 diabetes.
Herold KC; Delong T; Perdigoto AL; Biru N; Brusko TM; Walker LSK
Nat Rev Immunol; 2024 Jun; 24(6):435-451. PubMed ID: 38308004
[TBL] [Abstract][Full Text] [Related]
6. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy.
Siddiqui K; Nawaz SS
Immunotargets Ther; 2023; 12():91-103. PubMed ID: 37795196
[TBL] [Abstract][Full Text] [Related]
7. Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes.
Wenzlau JM; Gu Y; Michels A; Rewers M; Haskins K; Yu L
Diagnostics (Basel); 2023 Sep; 13(17):. PubMed ID: 37685398
[TBL] [Abstract][Full Text] [Related]
8. Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy.
Zhou L; Qu H; Zhang Q; Hu J; Shou L
Front Endocrinol (Lausanne); 2023; 14():1168927. PubMed ID: 37082120
[TBL] [Abstract][Full Text] [Related]
9. Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example.
Lichti CF; Wan X
Semin Immunol; 2023 Mar; 66():101730. PubMed ID: 36827760
[TBL] [Abstract][Full Text] [Related]
10. Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes.
Alhamar G; Briganti S; Maggi D; Viola V; Faraj M; Zannella C; Galdiero M; Franci G; Fusco C; Isgrò C; Leanza G; Malandrucco I; Spinelli A; Tramontana F; Iaria D; Tortoriello R; Pieralice S; Rosati M; Matarese G; Pozzilli P; Galgani M; Strollo R
J Clin Endocrinol Metab; 2023 Jun; 108(7):e474-e479. PubMed ID: 36611249
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications contribute to neoepitopes in Type-1 diabetes: Challenges for inducing antigen-specific tolerance.
Balakrishnan S; Kumar P; Prabhakar BS
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140478. PubMed ID: 32599298
[TBL] [Abstract][Full Text] [Related]
13. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes.
Mannering SI; Rubin AF; Wang R; Bhattacharjee P
Front Immunol; 2021; 12():667870. PubMed ID: 33995402
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
Strollo R; Vinci C; Man YKS; Bruzzaniti S; Piemonte E; Alhamar G; Briganti SI; Malandrucco I; Tramontana F; Fanali C; Garnett J; Buccafusca R; Guyer P; Mamula M; James EA; Pozzilli P; Ludvigsson J; Winyard PG; Galgani M; Nissim A
Diabetologia; 2023 Jan; 66(1):132-146. PubMed ID: 36207582
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to post-translationally modified insulin in type 1 diabetes.
Strollo R; Vinci C; Arshad MH; Perrett D; Tiberti C; Chiarelli F; Napoli N; Pozzilli P; Nissim A
Diabetologia; 2015 Dec; 58(12):2851-60. PubMed ID: 26350612
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.
Strollo R; Vinci C; Napoli N; Pozzilli P; Ludvigsson J; Nissim A
Diabetologia; 2017 Aug; 60(8):1467-1474. PubMed ID: 28526919
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
